John MacDonald

John has over 35 years of experience in all aspects of pharmaceutical drug development and licensing.  He led the preclinical and clinical R&D efforts at MGI Pharma, an oncology-focused company, from 1996 through 2005 and served as a consultant through MGI’s acquisition by Eisai in 2008.  Prior to MGI he worked in large pharma at Warner-Lambert and in academia as an NIH funded researcher at UC San Francisco. Since 2006 he has remained active in drug development as a consultant advising academic institutions, startup, and small pharma companies as the founder of Ridge Road Consulting.  Dr. MacDonald earned a Ph.D. in Pharmacology and Toxicology from the University of Arizona..